Cargando…
Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662166/ https://www.ncbi.nlm.nih.gov/pubmed/36387137 http://dx.doi.org/10.3389/fonc.2022.1063651 |
| _version_ | 1784830635043454976 |
|---|---|
| author | Loria, Rossella Vici, Patrizia Di Lisa, Francesca Sofia Soddu, Silvia Maugeri-Saccà, Marcello Bon, Giulia |
| author_facet | Loria, Rossella Vici, Patrizia Di Lisa, Francesca Sofia Soddu, Silvia Maugeri-Saccà, Marcello Bon, Giulia |
| author_sort | Loria, Rossella |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9662166 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96621662022-11-15 Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue Loria, Rossella Vici, Patrizia Di Lisa, Francesca Sofia Soddu, Silvia Maugeri-Saccà, Marcello Bon, Giulia Front Oncol Oncology Frontiers Media S.A. 2022-10-31 /pmc/articles/PMC9662166/ /pubmed/36387137 http://dx.doi.org/10.3389/fonc.2022.1063651 Text en Copyright © 2022 Loria, Vici, Di Lisa, Soddu, Maugeri-Saccà and Bon https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Loria, Rossella Vici, Patrizia Di Lisa, Francesca Sofia Soddu, Silvia Maugeri-Saccà, Marcello Bon, Giulia Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue |
| title | Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue |
| title_full | Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue |
| title_fullStr | Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue |
| title_full_unstemmed | Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue |
| title_short | Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue |
| title_sort | corrigendum: cross-resistance among sequential cancer therapeutics: an emerging issue |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662166/ https://www.ncbi.nlm.nih.gov/pubmed/36387137 http://dx.doi.org/10.3389/fonc.2022.1063651 |
| work_keys_str_mv | AT loriarossella corrigendumcrossresistanceamongsequentialcancertherapeuticsanemergingissue AT vicipatrizia corrigendumcrossresistanceamongsequentialcancertherapeuticsanemergingissue AT dilisafrancescasofia corrigendumcrossresistanceamongsequentialcancertherapeuticsanemergingissue AT soddusilvia corrigendumcrossresistanceamongsequentialcancertherapeuticsanemergingissue AT maugerisaccamarcello corrigendumcrossresistanceamongsequentialcancertherapeuticsanemergingissue AT bongiulia corrigendumcrossresistanceamongsequentialcancertherapeuticsanemergingissue |